+44 1300 500008Journal of Antivirals & Antiretrovirals : Citations & Metrics Report
Articles published in Journal of Antivirals & Antiretrovirals have been cited by esteemed scholars and scientists all around the world. Journal of Antivirals & Antiretrovirals has got h-index 22, which means every article in Journal of Antivirals & Antiretrovirals has got 22 average citations.
Following are the list of articles that have cited the articles published in Journal of Antivirals & Antiretrovirals.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total published articles |
59 | 57 | 32 | 59 | 77 | 13 | 11 | 20 | 37 | 22 | 37 | 55 | 22 | 12 |
Research, Review articles and Editorials |
1 | 0 | 5 | 42 | 32 | 12 | 10 | 14 | 27 | 21 | 33 | 44 | 21 | 10 |
Research communications, Review communications, Editorial communications, Case reports and Commentary |
48 | 57 | 27 | 17 | 45 | 1 | 1 | 6 | 10 | 1 | 4 | 11 | 1 | 2 |
Conference proceedings |
0 | 0 | 0 | 0 | 0 | 0 | 35 | 51 | 125 | 100 | 191 | 0 | 125 | 177 |
Citations received as per Google Scholar, other indexing platforms and portals |
98 | 160 | 172 | 269 | 223 | 172 | 219 | 195 | 170 | 116 | 60 | 36 | 26 | 58 |
| Journal total citations count | 2004 |
| Journal impact factor | 5.32 |
| Journal 5 years impact factor | 5.62 |
| Journal cite score | 5.3 |
| Journal h-index | 22 |
| Journal h-index since 2019 | 17 |
Important citations (1101)
khalid m, khan b, al rabiah f, alismaili r, saleemi s, et al. (2014) middle eastern respiratory syndrome corona virus (mers cov): case reports from a tertiary care hospital in saudi arabia. annals of saudi medicine 34: 396. |
|
memish za, assiri a, alhakeem r, yezli s, almasri m, et al. (2014) middle east respiratory syndrome corona virus, mers-cov. conclusions from the 2nd scientific advisory board meeting of the who collaborating center for mass gathering medicine, riyadh. international journal of infectious diseases: ijid: official publication of the international society for infectious diseases 24: 51. |
|
alsolamy s (2015) middle east respiratory syndrome: knowledge to date. critical care medicine 43: 1283-1290. |
|
cunha cb, opal sm (2014) middle east respiratory syndrome (mers) a new zoonotic viral pneumonia. virulence 5: 650-654. |
|
hui ds, zumla a (2014) advancing priority research on the middle east respiratory syndrome coronavirus. journal of infectious diseases 209: 173-176. |
|
arabi ym, harthi a, hussein j, bouchama a, johani s, et al. (2015) severe neurologic syndrome associated with middle east respiratory syndrome corona virus (mers-cov) infection 43: 495-501. |
|
al-tawfiq ja, zumla a, memish za (2014) coronaviruses: severe acute respiratory syndrome coronavirus and middle east respiratory syndrome coronavirus in travelers. current opinion in infectious diseases 27: 411-417. |
|
khalid m, al rabiah f, khan b, al mobeireek a, butt ts, et al. (2015) case report ribavirin and interferon-α2b as primary and preventive treatment for middle east respiratory syndrome coronavirus: a preliminary report of two cases. antiviral therapy 20: 87-91. |
|
al-tawfiq ja, memish za (2012) what are our pharmacotherapeutic options for mers-cov? |
|
spanakis n, tsiodras s, haagmans bl, raj vs, pontikis k, et al. (2014) virological and serological analysis of a recent middle east respiratory syndrome coronavirus infection case on a triple combination antiviral regimen. international journal of antimicrobial agents 44: 528-532. |
|
al-tawfiq ja, assiri a, memish za (2013) middle east respiratory syndrome novel corona (mers-cov) infection. epidemiology and outcome update. saudi medical journal 34: 991-994. |
|
faure e, poissy j, goffard a, fournier c, kipnis e, et al. (2014) distinct immune response in two mers-cov-infected patients: can we go from bench to bedside? plos one 9: e88716. |
|
al-tawfiq ja, hinedi k, ghandour j, khairalla h, musleh s, et al. (2014) middle east respiratory syndrome coronavirus: a case-control study of hospitalized patients. clinical infectious diseases 9: ciu226. |
|
memish za, zumla a, alhakeem rf, assiri a, turkestani a, et al. (2014) al harby kd, alyemni m, dhafar k, gautret p, barbeschi m, mccloskey b. hajj: infectious disease surveillance and control. the lancet 383: 2073-2082. |
|
omrani as, saad mm, baig k, bahloul a, abdul-matin m, et al. (2014) ribavirin and interferon alfa-2a for severe middle east respiratory syndrome coronavirus infection: a retrospective cohort study. the lancet infectious diseases 14: 1090-1095. |
|
al-tawfiq ja, momattin h, dib j, memish za (2014) ribavirin and interferon therapy in patients infected with the middle east respiratory syndrome coronavirus: an observational study. international journal of infectious diseases 20: 42-46. |
|
arabi ym, arifi aa, balkhy hh, najm h, aldawood as, et al. (2014) clinical course and outcomes of critically ill patients with middle east respiratory syndrome coronavirus infection. annals of internal medicine 160: 389-397. |
|
baghban-kohnehrouz b, nayeri s (2016) design, simplified cloning, and in-silico analysis of multisite small interfering rna-targeting cassettes. molecular biology research communications 5: 31. |
|
chaudhari a, pathakota gb, annam pk (2016) design and construction of shrimp antiviral dna vaccines expressing long and short hairpins for protection by rna interference. vaccine design: methods and protocols, volume 2: vaccines for veterinary diseases 2016: 225-240. |
|
escobedo-bonilla cm (2016) emerging infectious diseases affecting farmed shrimp in mexico. austin j biotechnol bioeng 3: 1062. |
|